Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by goldwatch69on Nov 17, 2018 5:50am
128 Views
Post# 28988943

RE:At the close

RE:At the closeOOPS!  Sorry, I forgot the bid ask is in 500 lots for penny stocks.  Ecliptick's Level II post shows the shares in depth and the lots at the top... 2.8 million on the bid at 11.5 and 60K on the ask at 12.    

Great support at 11 to 12.  There will be a bit of resistance waiting on the sidelines from the previous peak at 13 to 14.  The 13 cents sales could be someone hoarding 2 million that decided to take their profits or get their money back.  Anyone know who?  It would be good to know if it was Canaccord or MacQuarie. 

Volume should stay steady at this pace given the news stream and inventory sell outs.  Stay thirsty, my friends!
Bullboard Posts